ERBB2 and myocarditis: When the relationship between drugs and cardiovascular side effects was comprehensively assessed, HER2-associated drugs showed significant signals for cardiomyopathy and heart failure, whereas ALK-associated drugs demonstrated significant signals for heart failure, myocarditis, and pericarditis (Figure 3), suggesting that class-specific side effect profiles exist.